postmarket monitoring

FDA Publishes Discussion Paper on Regulating Generative AI-Enabled Med Devices

The FDA has opened a discussion on how generative AI-enabled medical devices should be assessed, evaluated, and monitored. The paper raises pointed questions for manufacturers about risk, premarket review, and postmarket performance of these emerging devices.

Digital Sponsors

Become a Sponsor

What's New

Understanding Arc Suppression: The Role of RC Networks in Protecting Electrical Contacts and Relays

FCC Provides Guides to Help Consumers Stop Robocalls, Texts

MIT Scientists Have Developed a Paper-Based Battery You Can Swallow

EOS/ESD Association, Inc. Announces 2026 Elected Officers and Board Members

FDA Issues Draft Guidance on Robotic Surgical Devices

- From Our Sponsors -